We’ve seen a growing number of private equity firms add management consultants to their investment teams over the last few years.
In this episode of The Charles Aris Podcast, we discuss biologicals with Jord Bioscience CEO Keri Carstens.
In this article, we explore how firms are deploying new corporate development hires to oversee multiple growth strategies.
Biological crop-protection products have the potential to compete with traditional crop-protection chemicals, but investors should practice thorough diligence.
In July, Charles Aris announced its Strategy Practice will expand to serve clients in need of go-to-market roles.
With over 50 years of experience, we’ve identified strategies that will ensure your next executive hire will help transform your organization for the better.